The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients
Clinical trial NCT04452929 · UNKNOWN
Trial details
- NCT number
- NCT04452929
- Sponsor
- Danish Headache Center
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-22
- Primary completion
- 2022-02-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.